Layered Embolic Sealing Device to Prevent Migration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Liquid embolic agents used for vascular treatments face a high risk of migration, limiting their application to specific conditions due to the inability to effectively seal the treatment site, particularly in aneurysms and arteriovenous malformations.

Innovation Solution

A sealing device with multiple layers, including a denser inner and looser outer mesh, is deployed to trap liquid embolic within the treatment area, utilizing a core wire for shape control and expansion to prevent migration, and can be delivered via a pusher system.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If liquid embolic is used for vascular treatment, then occlusive advantages are achieved, but high risk of migration occurs

Engineering Contradiction:
Improveocclusive effectivenessVSAvoidembolic migration risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The sealing device acts as an intermediary structure between the liquid embolic and the vascular system. It provides a physical barrier that contains the liquid embolic within the treatment site while allowing controlled delivery, thereby preventing migration while maintaining occlusive effectiveness.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The sealing device utilizes a flexible mesh structure that can conform to the treatment site geometry. This flexible shell configuration allows the device to adapt to irregular vascular structures while maintaining containment, preventing liquid embolic migration through its mesh architecture.

Inventive Principle:
Principle #30Flexible shells and thin films

2Object-affected harmful factors

If sealing device with multiple layers is deployed, then liquid embolic containment is improved, but device complexity increases

Engineering Contradiction:
Improveembolic migration preventionVSAvoidsealing device structure
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The sealing device is segmented into multiple layers with different mesh densities. The outer layer has a looser mesh for initial containment, while the inner layer has a denser mesh for secure trapping of liquid embolic. This segmentation allows each layer to perform its specific function, improving overall containment while maintaining manageable device complexity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Different regions of the sealing device have different mesh densities tailored to local requirements. The outer layer uses a looser mesh structure for initial containment and flexibility, while the inner layer uses a denser mesh for secure embolic trapping. This local differentiation of structural properties optimizes containment effectiveness without uniformly increasing complexity throughout the entire device.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The sealing device effectively contains liquid embolic within aneurysms and AVMs, allowing broader use of liquid embolic agents across various vascular conditions by preventing migration and ensuring occlusion.

Implementation Method 1

Liquid embolic is part of a newer class of compounds and are a type of biocompatible liquid which precipitates upon exposure to blood to harden and occlude a treatment site.

Methodology Applied
Scientific EffectPrecipitation: Precipitation

Data Source

PatentUS12383277B2Embolic containment
Publication Date: 2025.08.12 MICROVENTION INC
  • US12383277B2 patent drawing
  • US12383277B2 patent drawing
  • US12383277B2 patent drawing

AI summary

Devices, systems, and methods used to seal a treatment area to prevent embolic agents from migrating are described. The concept has particular benefit in allowing liquid embolic to be used with a variety of intravascular therapeutic applications, including for occluding aneurysms and arteriovenous malformations in the neurovasculature.